Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.

John De HeideChristiaan J VroeghRohit E BhagwandienSip A WijchersTamas Szili-TorokFelix ZijlstraMattie J LenzenSing-Chien Yap

Published in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2018)

In patients undergoing AF ablation, anticoagulation with minimally interrupted NOAC was associated with fewer clinically relevant non-major bleeding events in comparison with uninterrupted VKA without compromising thromboembolic safety.

Keyphrases

atrial fibrillation
catheter ablation
oral anticoagulants

left atrial
patients undergoing
left atrial appendage

direct oral anticoagulants
heart failure
percutaneous coronary intervention

venous thromboembolism
radiofrequency ablation
clinical evaluation